Helus Pharma Inc. (HELP) Stock Analysis & Investment Frameworks
Helus Pharma Inc. (HELP) stock analysis on Invetso. Review Helus Pharma Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Helus Pharma Inc. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Medical - Pharmaceuticals
- Country: CA
Helus Pharma Inc. Key Financial Metrics
- Market Cap: $520.05M
- Revenue: $-44.68M
- ROE: -74.47%
- ROIC: -70.77%
- Dividend Yield: N/A
About Helus Pharma Inc.
Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.